AMEX : AZTR
$0.0 (-1.07%)
%
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
-
-
change: 0.0 | last:
-
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-06-25 | Dauntless Investment Group, LLC | 5.8M | 9.60% |
| 2026-06-24 | Salva Francisco D. | 5.42M | 9.99% |
| 2026-06-22 | Stonepine Capital Management, LLC | 1.74M | 9.90% |
| 2025-12-19 | Alumni Capital LP | 1.13M | 9.99% |
| 2025-11-14 | L1 Capital Global Opportunities Master Fund, Ltd. | 273.5K | 2.60% |
| 2025-08-20 | Alumni Capital LP | 2.61M | 9.99% |
| 2025-08-14 | L1 Capital Global Opportunities Master Fund, Ltd. | 1.52M | 6.48% |
| 2025-05-15 | L1 Capital Global Opportunities Master Fund, Ltd. | 1.52M | 9.23% |
| 2025-05-14 | Ayrton Capital LLC | 1.66M | 9.99% |
| 2025-02-14 | L1 Capital Global Opportunities Master Fund, Ltd. | 960K | 7.15% |
| 2024-08-01 | Heights Capital Management, Inc. | 610K | 8.00% |
| 2024-08-01 | CVI Investments, Inc. | 610K | 8.00% |
| 2024-07-29 | L1 Capital Global Opportunities Master Fund, Ltd. | 776.38K | 9.99% |
| 2024-02-27 | Laurence W. Lytton | 1.67M | 11.00% |
| 2024-02-26 | Noam Dunsky | 1.5M | 5.20% |
| 2024-02-26 | Alpha 18 Inc. | 1.5M | 5.20% |
| 2024-02-12 | Bayer US Holding LP | 1.31M | 10.80% |
| 2024-02-12 | Bayer World Investments B.V. | 1.31M | 10.80% |
| 2024-02-12 | Bayer Aktiengesellschaft | 1.31M | 10.80% |
| 2024-02-12 | Bayer HealthCare LLC | 1.31M | 10.80% |
| 2023-07-03 | BIOS FUND II QP, LP | 1.1M | 9.00% |
| 2023-07-03 | BIOS FUND II NT, LP | 146.94K | 1.20% |
| 2023-07-03 | BIOS FUND III, LP | 404.77K | 3.30% |
| 2023-07-03 | BIOS FUND III QP, LP | 2.64M | 21.90% |
| 2023-07-03 | BIOS FUND III NT, LP | 426.94K | 3.50% |
| 2023-07-03 | BIOS AZITRA CO-INVEST I, LP | 475.93K | 3.90% |
| 2023-07-03 | BIOS EQUITY PARTNERS, LP | 1.27M | 10.50% |
| 2023-07-03 | BIOS EQUITY PARTNERS II, LP | 2.06M | 16.80% |
| 2023-07-03 | BIOS EQUITY PARTNERS III, LP | 3.48M | 28.80% |
| 2023-07-03 | BIOS CAPITAL MANAGEMENT, LP | 6.8M | 55.60% |
| 2023-07-03 | CAVU ADVISORS, LLC | 6.8M | 55.60% |
| 2023-07-03 | LESLIE WAYNE KREIS, JR. | 6.89M | 56.30% |
| 2023-07-03 | BIOS ADVISORS GP, LLC | 6.8M | 55.60% |
| 2023-07-03 | CAVU MANAGEMENT, LP | 6.8M | 55.60% |
| 2023-07-03 | BIOS FUND I, LP | 799.47K | 6.60% |
| 2023-07-03 | BIOS FUND I QP, LP | 467.61K | 3.90% |
| 2023-07-03 | BIOS FUND II, LP | 335.98K | 2.80% |
| 2023-07-03 | AARON GLENN LOUIS FLETCHER | 6.96M | 56.90% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.26 | 4.87M | $1.29M | $2.07M | $422.08K | -$355.49K |
| 2024-12-31 | $2.83 | 567.57K | $1.61M | $4.55M | $555.51K | -$2.39M |
| 2023-12-31 | $183.62 | 34514 | $6.34M | $1.8M | $885.95K | $5.43M |
| 2022-12-31 | $986.95 | 60492 | $59.7M | $3.49M | $7.73M | $63.94M |
| 2021-12-31 | $986.95 | 60492 | $59.7M | $8.04M | $992.02K | $52.65M |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.23 | 15.52M | $3.63M | $10.05M | $343.33K | -$6.08M |
| 2025-12-31 | $0.26 | 4.87M | $1.29M | $2.07M | $422.08K | -$355.49K |
| 2025-09-30 | $0.70 | 4.12M | $2.88M | $1.4M | $795.25K | $2.27M |
| 2025-06-30 | $1.74 | 2.44M | $4.25M | $1.05M | $577.86K | $3.79M |
| 2025-03-31 | $2.02 | 1.98M | $3.99M | $3.21M | $473.71K | $1.26M |
| 2024-12-31 | $2.83 | 1.15M | $3.24M | $4.55M | $555.51K | -$757.03K |
| 2024-09-30 | $3.62 | 873.02K | $3.16M | $7.26M | $643.35K | -$3.46M |
| 2024-06-30 | $22.64 | 144.16K | $3.26M | $803.08K | $722.66K | $3.18M |
| 2024-03-31 | $40.56 | 101.01K | $4.1M | $3M | $804.49K | $1.9M |
| 2023-12-31 | $183.62 | 60548 | $11.12M | $1.8M | $885.95K | $10.21M |
| 2023-09-30 | $299.83 | 60548 | $18.15M | $4.4M | $959.2K | $14.71M |
| 2023-06-30 | $727.41 | 10754 | $7.82M | $6.29M | $991.66K | $2.52M |